Of the 31 patients who were anti-MDA-5 positive, 15 had scleroderma-spectrum pattern abnormalities (1 with early and active, 14 with scleroderma-spectrum abnormalities unspecified in association with MDA-5 positivity). Here, IFIH1 is linked to scleroderma.